The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turnberg, D.
Right arrow Articles by Cook, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turnberg, D.
Right arrow Articles by Cook, H. T.
The Journal of Immunology, 2006, 177: 4094-4102.
Copyright © 2006 by The American Association of Immunologists, Inc.

Complement Activation Contributes to Both Glomerular and Tubulointerstitial Damage in Adriamycin Nephropathy in Mice1

Daniel Turnberg*, Margarita Lewis*, Jill Moss{dagger}, Yuanyuan Xu{ddagger}, Marina Botto* and H. Terence Cook2,{dagger}

* Rheumatology Section, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom; {dagger} Department of Histopathology, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom; and {ddagger} Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama, Birmingham, AL 35294

Adriamycin nephropathy is a model of focal segmental glomerulosclerosis, characterized by proteinuria and progressive glomerulosclerosis and tubulointerstitial damage. In this study, we examined the role of complement in the etiology of adriamycin nephropathy in mice. We used mice deficient in C1q, factor D, C3, and CD59, and compared them with strain-matched controls. C3 deposition occurred in the glomeruli of wild-type mice as early as 48 h following a single i.v. injection of adriamycin. C3-deficient mice developed significantly less proteinuria and less podocyte injury at day 3 postadriamycin than controls, suggesting that complement is important in mediating the early podocyte injury. At later time points, C3-deficient mice were protected from glomerulosclerosis, tubulointerstitial injury, and renal dysfunction. Factor D-deficient mice were also protected from renal disease, confirming the importance of alternative pathway activation in this model. In contrast, C1q-deficient mice developed similar disease to controls, indicating that the complement cascade was not activated via the classical pathway. CD59-deficient mice, which lack adequate control of C5b-9 formation, developed significantly worse histological and functional markers of renal disease than controls. Interestingly, although more C9 deposited in glomeruli of CD59-deficient mice than controls, in neither group was tubulointerstitial C9 staining apparent. We have demonstrated for the first time that alternative pathway activation of complement plays an important role in mediating the initial glomerular damage in this in vivo model of focal segmental glomerulosclerosis. Lack of CD59, which regulates the membrane attack complex, led to greater glomerular and tubulointerstitial injury.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Wellcome Trust Grant (071467). D.T. was a recipient of a fellowship from the National Kidney Research Fund.

2 Address correspondence and reprint requests to Dr. H. Terence Cook, Department of Histopathology, Faculty of Medicine, Hammersmith Campus, Imperial College, Du Cane Road, London, W12 0NN, U.K. E-mail address: t.cook{at}imperial.ac.uk

3 Abbreviations used in this paper: MAC, membrane attack complex; HPF, high-powered field.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Z. Tang, B. Lu, E. Hatch, S. H. Sacks, and N. S. Sheerin
C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. W. Pippin, P. T. Brinkkoetter, F. C. Cormack-Aboud, R. V. Durvasula, P. V. Hauser, J. Kowalewska, R. D. Krofft, C. M. Logar, C. B. Marshall, T. Ohse, et al.
Inducible rodent models of acquired podocyte diseases
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F213 - F229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Otaki, N. Miyauchi, M. Higa, A. Takada, T. Kuroda, F. Gejyo, F. Shimizu, and H. Kawachi
Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1376 - F1387.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate, C. Zoja, D. Corna, D. Rottoli, C. Zanchi, N. Azzollini, S. Tomasoni, S. Berlingeri, M. Noris, M. Morigi, et al.
Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1158 - 1167.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. S. Sheerin, P. Risley, K. Abe, Z. Tang, W. Wong, T. Lin, and S. H. Sacks
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury
FASEB J, April 1, 2008; 22(4): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. M. Lenderink, K. Liegel, D. Ljubanovic, K. E. Coleman, G. S. Gilkeson, V. M. Holers, and J. M. Thurman
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F555 - F564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.